《肝细胞癌诊疗规范（2022年版）》 - Suppr

Suppr

超能文献

[Standardization for diagnosis and treatment of hepatocellular carcinoma (2022 edition)].

出版信息

Zhonghua Gan Zang Bing Za Zhi. 2022 Apr 20;30(4):367-388. doi: 10.3760/cma.j.cn501113-20220413-00193.

DOI:10.3760/cma.j.cn501113-20220413-00193

PMID:35545562

Abstract

摘要

相似文献

[Standardization for diagnosis and treatment of hepatocellular carcinoma (2022 edition)].《肝细胞癌诊疗规范（2022年版）》

Zhonghua Gan Zang Bing Za Zhi. 2022 Apr 20;30(4):367-388. doi: 10.3760/cma.j.cn501113-20220413-00193.

[Hepatocellular carcinoma: diagnosis and multi-modality therapy].[肝细胞癌：诊断与多模态治疗]

Internist (Berl). 1997 Oct;38(10):954-62. doi: 10.1007/s001080050106.

Current status of treatment of hepatocellular carcinoma.肝细胞癌的治疗现状

Chin Med J (Engl). 1985 Apr;98(4):257-64.

[Diagnostic imaging and therapy of hepatocellular carcinoma].[肝细胞癌的诊断成像与治疗]

Dtsch Med Wochenschr. 1997 Dec 12;122(50):1573-5.

Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.肝细胞癌：ESMO关于诊断、治疗及随访的临床建议

Ann Oncol. 2008 May;19 Suppl 2:ii27-8. doi: 10.1093/annonc/mdn114.

[Current therapeutic strategies for hepatocellular carcinoma].[肝细胞癌的当前治疗策略]

MMW Fortschr Med. 2012 Jul 26;154(13):63-7; quiz 68-9. doi: 10.1007/s15006-012-0931-4.

Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma.肝细胞癌诊断、分期、治疗及监测中的影像学检查

AJR Am J Roentgenol. 2003 Feb;180(2):441-54. doi: 10.2214/ajr.180.2.1800441.

[Diagnosis and therapy of hepatocellular carcinoma].[肝细胞癌的诊断与治疗]

Med Klin (Munich). 1997 Nov 15;92(11):663-74. doi: 10.1007/BF03044823.

[Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)].《中国原发性肝癌诊疗规范（2019年版）》

Zhonghua Gan Zang Bing Za Zhi. 2020 Feb 20;28(2):112-128. doi: 10.3760/cma.j.issn.1007-3418.2020.02.004.

The effectiveness of selective internal radiation therapy in challenging cases of liver-predominant unresectable hepatocellular carcinoma.选择性内放射治疗在以肝脏为主的不可切除肝细胞癌疑难病例中的疗效。

Future Oncol. 2014 Nov;10(15 Suppl):17-27. doi: 10.2217/fon.14.218.

引用本文的文献

Efficacy and safety of D-TACE followed by D-RFA for unresectable large hepatocellular carcinoma.经动脉化疗栓塞术（D-TACE）联合射频消融术（D-RFA）治疗不可切除性大肝细胞癌的疗效与安全性

Front Oncol. 2025 Jul 28;15:1530951. doi: 10.3389/fonc.2025.1530951. eCollection 2025.

A CT-Based Deep Learning Radiomics Scoring System for Predicting the Prognosis to Repeat TACE in Patients with Hepatocellular Carcinoma: A Multicenter Cohort Study.基于CT的深度学习影像组学评分系统预测肝细胞癌患者重复经动脉化疗栓塞术的预后：一项多中心队列研究

J Hepatocell Carcinoma. 2025 Jul 29;12:1647-1659. doi: 10.2147/JHC.S525920. eCollection 2025.

Evaluating serum extra spindle pole bodies-like 1 protein p53 antibody for hepatitis B virus-related hepatocellular carcinoma diagnosis.评估血清额外纺锤极体样蛋白1抗体用于乙型肝炎病毒相关肝细胞癌的诊断

World J Hepatol. 2025 Jul 27;17(7):108850. doi: 10.4254/wjh.v17.i7.108850.

Transarterial chemoembolization versus hepatic arterial infusion chemotherapy as first treatment for hepatocellular carcinoma with macrovascular invasion.经动脉化疗栓塞术与肝动脉灌注化疗作为伴有大血管侵犯的肝细胞癌的一线治疗方法比较

Int J Med Sci. 2025 Feb 24;22(6):1415-1424. doi: 10.7150/ijms.108144. eCollection 2025.

Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition).《中国晚期原发性肝癌精准诊疗与管理专家共识（2023年版）》

Liver Res. 2024 May 27;8(2):61-71. doi: 10.1016/j.livres.2024.05.001. eCollection 2024 Jun.

Chinese expert consensus on the clinical application of molecular diagnostics in hepatobiliary cancers (2024 edition).《肝胆癌分子诊断临床应用中国专家共识（2024年版）》

Liver Res. 2024 Dec 3;8(4):195-206. doi: 10.1016/j.livres.2024.11.005. eCollection 2024 Dec.

Impact of Linggui Zhugan decoction on microwave ablation outcomes and recurrence in liver cancer.苓桂术甘汤对肝癌微波消融疗效及复发的影响

World J Gastrointest Oncol. 2025 Feb 15;17(2):101177. doi: 10.4251/wjgo.v17.i2.101177.

Development and verification of a nomogram for predicting portal vein tumor thrombosis in hepatocellular carcinoma.预测肝细胞癌门静脉肿瘤血栓形成的列线图的开发与验证

Am J Transl Res. 2024 Dec 15;16(12):7511-7520. doi: 10.62347/PLQF5135. eCollection 2024.

Baseline FIB-4 May Be a Risk Factor of Recurrence After SBRT in Patients With HBV-Related Small HCC.基线FIB-4可能是乙肝相关小肝癌患者接受立体定向放疗后复发的危险因素。

Cancer Med. 2025 Jan;14(1):e70535. doi: 10.1002/cam4.70535.

Novel techniques of liver segmental and subsegmental pedicle anatomy from segment 1 to segment 8.从第1段到第8段肝脏节段及亚节段蒂解剖的新技术。

World J Gastrointest Surg. 2024 Dec 27;16(12):3806-3817. doi: 10.4240/wjgs.v16.i12.3806.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验